EUVIMEDEUVIMED entdecken
Editorial

Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?

Roderick P P W M Maas iD

Movement Disorders · 2023

DOI: 10.1002/mds.29388 ↗

Kurz gefasst

Editorial in der Zeitschrift Movement Disorders, 2023. Verfasst von Roderick P P W M Maas. Beteiligte Einrichtung: Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Cerebellar Ataxia, Spinocerebellar Ataxias, Friedreich Ataxia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebellar AtaxiaSpinocerebellar AtaxiasFriedreich AtaxiaHumans

Stichwörter der Autor:innen

Friedreich ataxiaclinical trialsmultiple system atrophyoutcome measuresspinocerebellar ataxia

Autor:innen und Institutionen

  • Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

ORCID-Profile: Roderick P P W M Maas

Zitieren

APA

Maas, R. P. P. W. M. (2023). Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?. Movement Disorders. https://doi.org/10.1002/mds.29388

Vancouver

Maas RPPWM. Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?. Movement Disorders. 2023. doi:10.1002/mds.29388

BibTeX
@article{Maas2023,
  author = {Maas, Roderick P P W M},
  title = {Preparing for Disease‐Modification Trials in Degenerative Cerebellar Ataxias: Which Endpoints to Choose?},
  journal = {Movement Disorders},
  year = {2023},
  doi = {10.1002/mds.29388}
}
Kostenlos starten →